1993
DOI: 10.1016/0735-1097(93)90586-p
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic value of an increased in flourine-18 deoxyglucose uptake in patients with myocardial infarction: Comparision with stress thallium imaging

Abstract: Thus, an increase in F-18 deoxyglucose uptake seemed to be the best predictor of a future cardiac event among all clinical, angiographic and radionuclide variables in this study of stable patients with myocardial infarction. Even when a stress thallium-201 scan does not show redistribution, those patients who have an increase in F-18 deoxyglucose uptake in a PET study may be at risk for a future cardiac event, and these patients may need aggressive treatment to prevent a future cardiac event.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
19
0

Year Published

1999
1999
2008
2008

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 131 publications
(19 citation statements)
references
References 36 publications
0
19
0
Order By: Relevance
“…Risk stratification in patients with LV ischemic dysfunction typically includes a combination of clinical, hemodynamic, and angiographic parameters. 17 Recent studies using myocardial metabolic imaging with positron emission tomography (PET) have indicated that assessing myocardial viability also provides useful prognostic information in these patients, [17][18][19][20][21] with an effect additive to that of the usual clinical assessment. 21 Whereas PET is expensive and not widely available, exercise-redistribution-reinjection thallium scintigraphy and dobutamine echocardiography are less expensive and potentially more widely available methods that can also distinguish viable from nonviable myocardium.…”
Section: Discussionmentioning
confidence: 99%
“…Risk stratification in patients with LV ischemic dysfunction typically includes a combination of clinical, hemodynamic, and angiographic parameters. 17 Recent studies using myocardial metabolic imaging with positron emission tomography (PET) have indicated that assessing myocardial viability also provides useful prognostic information in these patients, [17][18][19][20][21] with an effect additive to that of the usual clinical assessment. 21 Whereas PET is expensive and not widely available, exercise-redistribution-reinjection thallium scintigraphy and dobutamine echocardiography are less expensive and potentially more widely available methods that can also distinguish viable from nonviable myocardium.…”
Section: Discussionmentioning
confidence: 99%
“…Both studies indicated that improvement in heart failure symptoms after revascularization occurred predominantly in patients with viable myocardium. Seven 18 F-FDG PET studies with 619 patients evaluated long-term prognosis in relation to treatment (medical and revascularization) and viability (absent or present) (27)(28)(29)(30)(31)(32)(33). Analysis of the pooled data demonstrated that the highest event rate was observed in patients who had viable myocardium and who were treated medically, whereas patients who had viable myocardium and who underwent revascularization had the best prognosis (Table 6).…”
Section: Nuclear Imaging By Pet With 18 F-fdgmentioning
confidence: 99%
“…Even if some myocardial segments showed severe contractile dysfunction, left ventricular global and regional contractility may recover owing to viable segments. Non-invasive myocardial viability assessment thus has been considered important, and various approaches have been utilized including contractile functional reserve by echocardiography with inotropic stimulation, myocardial perfusion imaging with single-photon emission computed tomography (SPECT) and positron emission tomography with 18 F-fuluorodeoxyglucose (FDG) [1][2][3][4][5][6]. Although FDG may provide better diagnostic ability for detecting potentially reversible myocardial dysfunction, single-photon myocardial perfusion tracers continue to be one of the best convenient choices for clinical practice.…”
Section: Introductionmentioning
confidence: 99%